Key Insights
The South Korea self-monitoring blood glucose (SMBG) devices market, valued at $7.32 million in 2025, is projected to experience steady growth, driven primarily by the rising prevalence of diabetes and an aging population. A Compound Annual Growth Rate (CAGR) of 1.90% suggests a gradual but consistent expansion over the forecast period (2025-2033). Key market segments include glucometer devices, test strips, and lancets. The market is moderately competitive, with major players like i-Sens, Roche Diabetes Care, Acon Laboratories, Abbott Diabetes Care, Medisana, and LifeScan vying for market share. Increased government initiatives focused on diabetes management and improved healthcare infrastructure are likely to contribute positively to market growth. However, factors such as the high cost of SMBG devices and the emergence of continuous glucose monitoring (CGM) systems might act as restraints, potentially limiting the overall growth rate of the SMBG market. The growing preference for convenient and less invasive CGM technology could influence market dynamics in the long term, impacting the demand for traditional SMBG devices, particularly glucometers and test strips. The market is expected to show continuous growth primarily driven by technological advancements within the glucometer device sector. This segment will likely drive increased affordability and user-friendliness, impacting the overall growth of the South Korean SMBG market. Further research into specific market segment growth will be crucial to precisely predict future trends.
The South Korea SMBG market shows promising potential despite the anticipated constraints. Companies will need to focus on innovation and product differentiation to maintain a competitive edge. Strategic partnerships with healthcare providers and government initiatives will prove essential for widespread adoption and market expansion. An increase in public awareness campaigns regarding diabetes prevention and management could further boost market demand. Analyzing regional variations in market growth within South Korea will be crucial to understanding the complete market dynamics. The overall outlook indicates sustainable growth, although the rate might be influenced by technological advances and shifts in consumer preferences towards newer blood glucose monitoring technologies.

South Korea Self-Monitoring Blood Glucose Devices Market Report: 2019-2033
This comprehensive report provides a detailed analysis of the South Korea self-monitoring blood glucose devices market, offering invaluable insights for stakeholders across the industry. Covering the period 2019-2033, with a focus on 2025, this report meticulously examines market dynamics, competitive landscapes, and future growth prospects. Benefit from in-depth analysis of market size, segmentation (Glucometer Devices, Test Strips, Lancets), leading players, and key industry trends to make informed business decisions.
South Korea Self-Monitoring Blood Glucose Devices Market Dynamics & Concentration
This section analyzes the South Korea self-monitoring blood glucose devices market's concentration, identifying key drivers of innovation, regulatory influences, and competitive pressures. We examine market share distribution among key players and evaluate the impact of mergers and acquisitions (M&A) activities.
Market Concentration: The market exhibits a moderately concentrated structure, with the top five players (i-Sens, Roche Diabetes Care, Acon Laboratories, Abbott Diabetes Care, LifeScan) holding an estimated xx% market share in 2025. Other players, including Medisana, Bionime Corporation, and Arkray Inc., contribute to the remaining market share.
Innovation Drivers: Technological advancements, such as the integration of Bluetooth connectivity and mobile apps (as evidenced by LifeScan's 2023 announcement), drive market growth. The potential for integration with advanced displays (as highlighted by Samsung's 2022 announcement) promises further innovation.
Regulatory Framework: Stringent regulatory approvals and healthcare policies influence market access and product development. The impact of these regulations on market entry and expansion will be thoroughly assessed.
Product Substitutes: While limited, the availability of alternative diabetes management solutions creates competitive pressure within the market.
End-User Trends: Increasing awareness of diabetes and the growing elderly population contribute to market expansion. Changing consumer preferences for user-friendly, connected devices also shape market dynamics.
M&A Activity: The report analyzes past and potential future M&A activities, examining their impact on market consolidation and competitive intensity. An estimated xx M&A deals occurred within the observed period.
South Korea Self-Monitoring Blood Glucose Devices Market Industry Trends & Analysis
This section delves into the key industry trends shaping the South Korea self-monitoring blood glucose devices market. We explore market growth drivers, technological disruptions, evolving consumer preferences, and competitive dynamics. The analysis incorporates key metrics such as CAGR and market penetration rates. Market size is projected to reach xx Million by 2033, exhibiting a CAGR of xx% during the forecast period (2025-2033). This growth is driven by factors such as rising diabetes prevalence, increasing disposable income, and government initiatives promoting better diabetes management. Technological advancements, particularly in connectivity and data analysis, are pivotal in shaping market trends. Consumer preference shifts towards smart, user-friendly devices further fuels the market’s expansion. Competitive dynamics are characterized by a mix of established players and emerging competitors, creating both opportunities and challenges.

Leading Markets & Segments in South Korea Self-Monitoring Blood Glucose Devices Market
This section identifies the dominant segments within the South Korea self-monitoring blood glucose devices market: Glucometer Devices, Test Strips, and Lancets. The analysis includes a regional breakdown to pinpoint areas of highest market concentration.
Dominant Segment: Glucometer Devices constitute the largest segment, holding an estimated xx% market share in 2025 due to continuous technological advancements and increasing demand for convenient self-monitoring tools.
Key Drivers:
- Rising Prevalence of Diabetes: The escalating number of individuals diagnosed with diabetes in South Korea is a primary driver of market growth across all segments.
- Government Initiatives: Government support for diabetes management programs and healthcare infrastructure development contributes to market expansion.
- Economic Factors: Increasing disposable incomes enable greater access to advanced self-monitoring blood glucose devices.
South Korea Self-Monitoring Blood Glucose Devices Market Product Developments
Recent product innovations focus on improved accuracy, connectivity, and user-friendliness. Integration with mobile apps and data analytics platforms enables enhanced disease management. Technological trends are heavily influencing product development, leading to smaller, more portable devices with improved accuracy. Market fit is driven by addressing specific consumer needs and regulatory requirements.
Key Drivers of South Korea Self-Monitoring Blood Glucose Devices Market Growth
The market's growth is propelled by several factors: the increasing prevalence of diabetes, technological advancements resulting in more user-friendly and accurate devices, and government support for better diabetes management. Economic growth and rising disposable incomes also contribute significantly to market expansion.
Challenges in the South Korea Self-Monitoring Blood Glucose Devices Market
The market faces challenges, including stringent regulatory approvals, potential supply chain disruptions, and intense competition from both domestic and international players. Price sensitivity among consumers and the need for continuous innovation to stay competitive also pose challenges.
Emerging Opportunities in South Korea Self-Monitoring Blood Glucose Devices Market
Significant opportunities exist in integrating advanced technologies like AI and machine learning for better data analysis and personalized diabetes management. Strategic partnerships, focusing on integrating these devices with broader healthcare ecosystems, present further growth opportunities. Expansion into underserved regions and the development of cost-effective devices also hold potential.
Leading Players in the South Korea Self-Monitoring Blood Glucose Devices Market Sector
- i-Sens
- Roche Diabetes Care
- Acon Laboratories
- Abbott Diabetes Care
- Medisana
- LifeScan
- Other Company Share Analyse
- Bionime Corporation
- Arkray Inc
Key Milestones in South Korea Self-Monitoring Blood Glucose Devices Market Industry
- January 2023: LifeScan's publication of real-world data on improved glycemic control using a connected blood glucose meter and mobile app highlights the growing importance of integrated solutions.
- December 2022: Samsung's announcement of advanced display technology with integrated biosensors suggests future possibilities for more integrated health monitoring devices, including blood glucose monitoring.
Strategic Outlook for South Korea Self-Monitoring Blood Glucose Devices Market Market
The South Korea self-monitoring blood glucose devices market holds significant potential for continued growth driven by technological innovation, increasing diabetes prevalence, and supportive government policies. Strategic partnerships and market expansion initiatives will be crucial for maximizing future opportunities. The market is poised for robust expansion, driven by both technological advancements and a growing need for efficient diabetes management.
South Korea Self-Monitoring Blood Glucose Devices Market Segmentation
-
1. Component
- 1.1. Glucometer Devices
- 1.2. Test Strips
- 1.3. Lancets
South Korea Self-Monitoring Blood Glucose Devices Market Segmentation By Geography
- 1. South Korea

South Korea Self-Monitoring Blood Glucose Devices Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 1.90% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Rising Diabetes Prevalence in South Korea
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. South Korea Self-Monitoring Blood Glucose Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Component
- 5.1.1. Glucometer Devices
- 5.1.2. Test Strips
- 5.1.3. Lancets
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. South Korea
- 5.1. Market Analysis, Insights and Forecast - by Component
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 i-Sens
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Roche Diabetes Care
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Acon Laboratories
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Abbott Diabetes Care
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Medisana
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 LifeScan
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Other Company Share Analyse
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Bionime Corporation*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Arkray Inc
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 i-Sens
List of Figures
- Figure 1: South Korea Self-Monitoring Blood Glucose Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: South Korea Self-Monitoring Blood Glucose Devices Market Share (%) by Company 2024
List of Tables
- Table 1: South Korea Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: South Korea Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Component 2019 & 2032
- Table 3: South Korea Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 4: South Korea Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Component 2019 & 2032
- Table 5: South Korea Self-Monitoring Blood Glucose Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the South Korea Self-Monitoring Blood Glucose Devices Market?
The projected CAGR is approximately 1.90%.
2. Which companies are prominent players in the South Korea Self-Monitoring Blood Glucose Devices Market?
Key companies in the market include i-Sens, Roche Diabetes Care, Acon Laboratories, Abbott Diabetes Care, Medisana, LifeScan, Other Company Share Analyse, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, Bionime Corporation*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Arkray Inc.
3. What are the main segments of the South Korea Self-Monitoring Blood Glucose Devices Market?
The market segments include Component.
4. Can you provide details about the market size?
The market size is estimated to be USD 7.32 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Rising Diabetes Prevalence in South Korea.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes - one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "South Korea Self-Monitoring Blood Glucose Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the South Korea Self-Monitoring Blood Glucose Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the South Korea Self-Monitoring Blood Glucose Devices Market?
To stay informed about further developments, trends, and reports in the South Korea Self-Monitoring Blood Glucose Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence